TP53 and cancer: SPINK7(serine peptidase inhibitor, Kazal type 7 (putative)) targeted by miR-1322[52] by inhibiting invasion of cancer cells via the urokinase-type plasmin activator receptor 1 integrin pathway or by upregulating p53 expression was considered as a tumor suppressor in multiple types cancers [53–55].